Literature DB >> 21059367

Alzheimer-associated mutant ubiquitin impairs spatial reference memory.

Paula van Tijn1, Barbara Hobo, Marian C Verhage, Melly S Oitzl, Fred W van Leeuwen, David F Fischer.   

Abstract

UBB(+1) is a mutant ubiquitin which accumulates in the hallmarks of tauopathies, including Alzheimer's disease. Transgenic mice expressing high levels of neuronal UBB(+1) exhibit moderately decreased proteasome activity and spatial reference memory deficits at 9months of age. In the present study, we characterized the behavioral phenotype of male UBB(+1) transgenic mice at different ages. We show that UBB(+1) transgenic mice displayed an age-related functional decline similar to wild-type littermates, without gross neurological abnormalities or alterations in procedural motor-learning and motor coordination. At 15months of age, a transgene-specific spatial learning deficit was dependent on the period of training in the Morris watermaze. This deficit could be eliminated after additional training. We conclude that the previously reported spatial reference memory deficits of UBB(+1) transgenic mice persist during aging. In addition, our results demonstrate that the subtle defect in spatial reference memory formation, caused by a decrease in forebrain proteasome activity, is a persistent defect and not a structural defect.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059367     DOI: 10.1016/j.physbeh.2010.11.001

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  7 in total

1.  Proteasome regulates transcription-favoring histone methylation, acetylation and ubiquitination in long-term synaptic plasticity.

Authors:  Svitlana V Bach; P Ryan Tacon; James W Morgan; Ashok N Hegde
Journal:  Neurosci Lett       Date:  2015-02-14       Impact factor: 3.046

Review 2.  Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins.

Authors:  Ralf J Braun
Journal:  Front Mol Neurosci       Date:  2015-03-12       Impact factor: 5.639

3.  Localization of mutant ubiquitin in the brain of a transgenic mouse line with proteasomal inhibition and its validation at specific sites in Alzheimer's disease.

Authors:  Romina J G Gentier; Bert M Verheijen; Margherita Zamboni; Maartje M A Stroeken; Denise J H P Hermes; Benno Küsters; Harry W M Steinbusch; David A Hopkins; Fred W Van Leeuwen
Journal:  Front Neuroanat       Date:  2015-03-17       Impact factor: 3.856

Review 4.  The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury.

Authors:  Bing Gong; Miroslav Radulovic; Maria E Figueiredo-Pereira; Christopher Cardozo
Journal:  Front Mol Neurosci       Date:  2016-01-26       Impact factor: 5.639

5.  Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease.

Authors:  Xuefeng Gu; Donglin Lai; Shuang Liu; Kaijie Chen; Peng Zhang; Bing Chen; Gang Huang; Xiaoqin Cheng; Changlian Lu
Journal:  Front Aging Neurosci       Date:  2022-07-07       Impact factor: 5.702

6.  Selective Transgenic Expression of Mutant Ubiquitin in Purkinje Cell Stripes in the Cerebellum.

Authors:  Bert M Verheijen; Romina J G Gentier; Denise J H P Hermes; Fred W van Leeuwen; David A Hopkins
Journal:  Cerebellum       Date:  2017-06       Impact factor: 3.847

Review 7.  Perturbations of Ubiquitin-Proteasome-Mediated Proteolysis in Aging and Alzheimer's Disease.

Authors:  Ashok N Hegde; Spencer G Smith; Lindsey M Duke; Allison Pourquoi; Savannah Vaz
Journal:  Front Aging Neurosci       Date:  2019-12-06       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.